Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions

Panminerva Medica

Volumn 40, Issue 3, 1998, Pages 186-190

  Bobbio Pallavicini, E ^a   Confalonieri, M ^a   Tacconi, F ^a   Mainardi, E ^a   Della Porta, R ^b   Ceccato, D ^b   Maccario, R ^b   De Amici, M ^b,c  

^a MAGGIORE HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Blood proteins; Cations; Eosinophilia; Eosinophils; Hypereosinophilic syndrome

Indexed keywords

EOSINOPHIL GRANULE PROTEIN; EOSINOPHIL PROTEIN X; PLASMA PROTEIN; RIBONUCLEASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; FEMALE; HUMAN; HYPEREOSINOPHILIC SYNDROME; MALE; METABOLISM; MIDDLE AGED; SECRETION;

ADOLESCENT; ADULT; AGED; BLOOD PROTEINS; CHILD; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; FEMALE; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; MIDDLE AGED; RIBONUCLEASES;

EID: 0032159399     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of 14 cases with review of the literature. Medicine 1975;54:1-27
2. Thorne KJI, Mazza G, Eosinophilia. activated eosinophils and human schistosomiasis. J Cell Sci 1991;98:265-70.
3. Bonini S, Tomassini M, Adriani E, Magrini L, Rumi C, Bussa S et al. Markers of eosinophilic inflammation in allergic diseases. Allergy 1993;48:133-7.
4. Fukuda T, Gleich GJ. Heterogeneity of human eosinophils. J Allergy Clin Immunol 1989;83:369-73.
5. Peters MS, Cleich GJ, Dunette SL, Fukuda T. Ultrastructural study of eosinophils from patients with hypereosinophilic syndrome: a morphologic basis of hypodense eosinophils. Blood 1988;71:780-5.
6. Barker RL, Loegering DA, Ten RM, Hamman KJ, Pease LA, Gleich GJ. Eosinophil cationic protein cDNA: comparison with other toxic cationic proteins and ribonucleases. J Immunol 1989;143: 952-5.
7. Carlson M, Håkansson L, Kämpe M, Stålenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991;87:27-33.
8. Venge P. Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP). A new clinical approach to asthma management. Respir Med 1995;98:1-2.
9. Tai PC, Sry CJF, Peterson C, Venge P, Olsson I. Monoclonal antibody distinguishes between storage and secreted forms of eosinophil cationic protein. Nature 1984;309:182-4.
10. Reimert CM, Poulsen LK, Bindslev-Jensen C, Kharazmi A, Bendzen K. Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Time and temperature dependent spontaneous release in vitro demands standardized sample processing. J Immunol Methods 1993;166:183-90.
11. Halldén G, Anderson U, Hed J, Johansson SGO. A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry. J Immunol Methods 1989;124:103-9.
12. Skoog WA, Beck WS. Study on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes. Blood J Hematol 1956;11:466-72.
13. Peterson CG, Enander I, Nystrand J, Anderson AS, Nilsson L, Venge P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991;21:561-5.
14. Sokal RR, Rohlf FJ. Biometry: the principles and practice of statistics in biological research. San Francisco. WH Freeman, 1969.
15. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-79.
16. Cassi E, DePaoli A, Fava S. Idiopathic hypereosinophilic syndrome and eosinophilic leukemia. Haematologica 1992;77:430-2.
17. Carlson M, Öberg G, Peterson C, Venge P. Releasability of human hypereosinophilic eosinophils is related to the density of the cells. Br J Haematol 1994;86.41-7.
18. Confalonieri M, Tacconi F, DeAmici M, Maccario R, Porta C, Gioglio L et al. Benign idiopathic hypereosinophilia: a feeble masquerader or a smouldering form of the hypereosinophilic syndrome? Haematologica 1995;80:50-3.
19. Plumas J, Gruart V, Aldebert D, Truong MJ, Capron M, Capron A et al. Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 IL-2 receptor subunit. Eur J Immunol 1991;21:1265.
20. Capron M. Receptors and mechanisms of activation of eosinophils. In: Godard Ph, Bousquet J, Michel FB, editors. Advances in Allergology and Clinical Immunology. Carnforth UK: The Partenon Publishing Group, 1992:187-94.
21. Carlson M, Peterson C, Venge P. The influence of IL-3, IL-5 and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation. Allergy 1993;48:437-32.